Group II metabotropic glutamate receptors and schizophrenia

被引:49
|
作者
Moreno, Jose L. [1 ,3 ]
Sealfon, Stuart C. [2 ,4 ]
Gonzalez-Maeso, Javier [1 ,2 ,3 ]
机构
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Div Basic Neurosci, New York, NY 10029 USA
[4] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA
关键词
Schizophrenia; Antipsychotics; G protein-coupled receptors (GPCR); Serotonin receptors; 5-HT2A; Metabotropic glutamate receptors; mGluR2; mGluR3; PROTEIN-COUPLED RECEPTOR; TYPE-3 GENE GRM3; DORSOLATERAL PREFRONTAL CORTEX; CATECHOL-O-METHYLTRANSFERASE; ATYPICAL ANTIPSYCHOTICS; WORKING-MEMORY; OBSTETRIC COMPLICATIONS; ACTIVATION MECHANISM; MOLECULAR-MECHANISMS; HALLUCINOGENIC DRUG;
D O I
10.1007/s00018-009-0130-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Schizophrenia is one of the most common mental illnesses, with hereditary and environmental factors important for its etiology. All antipsychotics have in common a high affinity for monoaminergic receptors. Whereas hallucinations and delusions usually respond to typical (haloperidol-like) and atypical (clozapine-like) monoaminergic antipsychotics, their efficacy in improving negative symptoms and cognitive deficits remains inadequate. In addition, devastating side effects are a common characteristic of monoaminergic antipsychotics. Recent biochemical, preclinical and clinical findings support group II metabotropic glutamate receptors (mGluR2 and mGluR3) as a new approach to treat schizophrenia. This paper reviews the status of general knowledge of mGluR2 and mGluR3 in the psychopharmacology, genetics and neuropathology of schizophrenia.
引用
收藏
页码:3777 / 3785
页数:9
相关论文
共 50 条
  • [1] Group II metabotropic glutamate receptors and schizophrenia
    José L. Moreno
    Stuart C. Sealfon
    Javier González-Maeso
    Cellular and Molecular Life Sciences, 2009, 66 : 3777 - 3785
  • [2] The role of group I metabotropic glutamate receptors in schizophrenia
    M. Pietraszek
    J. Nagel
    A. Gravius
    D. Schäfer
    W. Danysz
    Amino Acids, 2007, 32 : 173 - 178
  • [3] The role of group I metabotropic glutamate receptors in schizophrenia
    Pietraszek, M.
    Nagel, J.
    Gravius, A.
    Schaefer, D.
    Danysz, W.
    AMINO ACIDS, 2007, 32 (02) : 173 - 178
  • [4] In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptors
    Dedeurwaerdere, Stefanie
    Boets, Stephanie
    Janssens, Pieter
    Lavreysen, Hilde
    Steckler, Thomas
    ACTA NEUROLOGICA BELGICA, 2015, 115 (03) : 221 - 232
  • [5] In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptors
    Stefanie Dedeurwaerdere
    Stephanie Boets
    Pieter Janssens
    Hilde Lavreysen
    Thomas Steckler
    Acta Neurologica Belgica, 2015, 115 : 221 - 232
  • [6] GROUP I AND II METABOTROPIC GLUTAMATE RECEPTORS IN THE HUMAN PREFRONTAL AND TEMPORAL CORTEX: DIFFERENCES IN SCHIZOPHRENIA
    Ghose, Subroto
    Gleason, K.
    Potts, B.
    Amezcua, K.
    Tamminga, C.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 233 - 233
  • [7] Pharmacology and function of native group II metabotropic glutamate receptors
    Kemp, JA
    Knoflach, F
    Kew, JNC
    Adam, G
    Woltering, T
    Mutel, V
    NEUROPHARMACOLOGY, 1999, 38 (10) : A22 - A22
  • [8] Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors
    DiRaddo, John O.
    Miller, Eric J.
    Bowman-Dalley, Carrie
    Wroblewska, Barbara
    Javidnia, Monica
    Grajkowska, Ewa
    Wolfe, Barry B.
    Liotta, Dennis C.
    Wroblewski, Jarda T.
    MOLECULAR PHARMACOLOGY, 2015, 88 (03) : 450 - 459
  • [9] Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors
    Kawashima, N
    Karasawa, J
    Shimazaki, T
    Chaki, S
    Okuyama, S
    Yasuhara, A
    Nakazato, A
    NEUROSCIENCE LETTERS, 2005, 378 (03) : 131 - 134
  • [10] Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus Accumbens
    Xi, ZX
    Baker, DA
    Shen, H
    Carson, DS
    Kalivas, PW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (01): : 162 - 171